Category: Company News

New Trial Shows Cefaly is a Safe and Effective Preventive Treatment for Chronic Migraine

A new open-label trial, published by Birlea et al. in the peer-reviewed journal for the International Headache Society, Cephalalgia, concluded using the Cefaly medical device as a preventive treatment for chronic migraine headache is safe and effective. A pilot trial

Tagged with: , , , , , , , , , , , , , , , , , ,

4 Drug-Free Tips to Outsmart a Migraine this 4th of July

Free yourself from migraines this Independence Day with a little planning and non-invasive methods that won’t dampen your mood or impede upon your festivities Cefaly® the first device of its kind to receive U.S. Food and Drug Administration (FDA) approval

Tagged with: , , , , , , , , , ,

A Major Study About the Acute Treatment of Migraine Using Cefaly Is Published in the Journal of The International Headache Society

Cephalalgia, the official peer-reviewed medical journal of the International Headache Society, has just published positive results of the American multicentric clinical trial ACME (ACute Migraine therapy with External trigeminal neurostimulation: randomized controlled trial) implemented at Yale and Columbia Universities and

Tagged with: , , , , , , , , , , , , , ,

Migraine: Two Published Articles Confirm the Basics of the Cefaly Medical Device

Two new scientific published articles in the peer-reviewed magazine of the International Headache Society, confirm the basic mechanism of the Cefaly® device and detail its effect on the nervous system for the treatment of migraine. The findings confirm remarkable central

Tagged with: , , , , , , , , , , , , ,

Migraine Abortion Phase 3 Trial (TEAM study) with Cefaly® ACUTE Medical Device is Progressing Quickly

The Cefaly® ACUTE medical device, recently cleared by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine, is the subject of a large phase 3 clinical trial in the United States that is progressing rapidly. Previous

Tagged with: , , , , , , , ,